Comparison of National and Global Asthma Management Guiding Documents

被引:5
作者
Baker, Joyce A. [1 ,2 ]
Houin, Paul R. [1 ]
机构
[1] Childrens Hosp Colorado, Breathing Inst, Aurora, CO USA
[2] Childrens Hosp Colorado, Breathing Inst, 13123 16th Ave, Aurora, CO 80045 USA
关键词
Acute disease; Asthma; Chronic disease; Guidelines; Medications; Patient care management; EXHALED NITRIC-OXIDE; MILD PERSISTENT ASTHMA; MITE SUBLINGUAL IMMUNOTHERAPY; BRONCHIAL THERMOPLASTY; BUDESONIDE-FORMOTEROL; PRESCHOOL-CHILDREN; DOUBLE-BLIND; INHALED CORTICOSTEROIDS; ALLERGIC RHINITIS; TO-MODERATE;
D O I
10.4187/respcare.10254
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Asthma is a common chronic disease that affects both adults and children, and that continues to have a high economic burden. Asthma management guidelines were first developed nearly 30 years ago to standardize care, maintain asthma control, improve quality of life, maintain normal lung function, prevent exacerbations, and prevent asthma mortality. The two most common asthma guidelines used today were developed by the National Asthma Education and Prevention Program (NAEPP) Expert Panel Working Group and the Global Initiative for Asthma Science Committee. Both guiding documents use scientific methodology to standardize their approach for formulating recommendations based on pertinent literature. Before the 2020 National Asthma Education and Prevention Program (Expert Panel Report 4), nothing had been released since the 2007 guidelines, whereas the Global Initiative for Asthma publishes updates annually. Although each of these asthma strategies is similar, there are some noted differences. Over the years, the focus of asthma treatment has shifted from acute to chronic management. Frontline respiratory therapists and other health-care providers should have a good understanding of these 2 guiding references and how they can impact acute and chronic asthma management. The primary focus of this narrative is to look at the similarities and differences of these 2 guiding documents as they pertain to the 6 key questions identified by the Expert Panel of the National Asthma Education and Prevention Program
引用
收藏
页码:114 / 128
页数:15
相关论文
共 110 条
[21]   Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial [J].
Castro, Mario ;
Rubin, Adalberto S. ;
Laviolette, Michel ;
Fiterman, Jussara ;
Lima, Marina De Andrade ;
Shah, Pallav L. ;
Fiss, Elie ;
Olivenstein, Ronald ;
Thomson, Neil C. ;
Niven, Robert M. ;
Pavord, Ian D. ;
Simoff, Michael ;
Duhamel, David R. ;
McEvoy, Charlene ;
Barbers, Richard ;
ten Hacken, Nicolaas H. T. ;
Wechsler, Michael E. ;
Holmes, Mark ;
Phillips, Martin J. ;
Erzurum, Serpil ;
Lunn, William ;
Israel, Elliot ;
Jariour, Nizar ;
Kraft, Monica ;
Shargill, Narinder S. ;
Quiring, John ;
Berry, Scott M. ;
Cox, Gerard .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (02) :116-124
[22]  
Centers for Disease Control and Prevention, Most Recent National Asthma Data
[23]   2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group [J].
Cloutier, Michelle M. ;
Baptist, Alan P. ;
Blake, Kathryn V. ;
Brooks, Edward G. ;
Bryant-Stephens, Tyra ;
DiMango, Emily ;
Dixon, Anne E. ;
Elward, Kurtis S. ;
Hartert, Tina ;
Krishnan, Jerry A. ;
Lemanske, Robert F., Jr. ;
Ouellette, Daniel R. ;
Pace, Wilson D. ;
Schatz, Michael ;
Skolnik, Neil S. ;
Stout, James W. ;
Teach, Stephen J. ;
Umscheid, Craig A. ;
Walsh, Colin G. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (06) :1217-1270
[24]   Asthma maintenance and reliever therapy Should this be the standard of care? [J].
Cusack, Ruth P. ;
Satia, Imran ;
O'Byrne, Paul M. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (02) :150-155
[25]   Emerging understanding of the mechanism of action of Bronchial Thermoplasty in asthma [J].
d'Hooghe, J. N. S. ;
ten Hacken, N. H. T. ;
Weersink, E. J. M. ;
Sterk, P. J. ;
Annema, J. T. ;
Bonta, P. I. .
PHARMACOLOGY & THERAPEUTICS, 2018, 181 :101-107
[26]   SQ HDM SLIT-tablet (ALK) in treatment of asthma - Post hoc results from a randomised trial [J].
de Blay, F. ;
Kuna, P. ;
Prieto, L. ;
Ginko, T. ;
Seitzberg, D. ;
Riis, B. ;
Canonica, G. W. .
RESPIRATORY MEDICINE, 2014, 108 (10) :1430-1437
[27]   Allergic rhinitis is associated with poor asthma control in children with asthma [J].
de Groot, Eric P. ;
Nijkamp, Anke ;
Duiverman, Eric J. ;
Brand, Paul L. P. .
THORAX, 2012, 67 (07) :582-587
[28]   Daily Telemonitoring of Exhaled Nitric Oxide and Symptoms in the Treatment of Childhood Asthma [J].
de Jongste, Johan C. ;
Carraro, Silvia ;
Hop, Wim C. ;
Baraldi, Eugenio .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (02) :93-97
[29]   House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial [J].
Devillier, P. ;
Fadel, R. ;
de Beaumont, O. .
ALLERGY, 2016, 71 (02) :249-257
[30]   Preemptive Use of High-Dose Fluticasone for Virus-Induced Wheezing in Young Children. [J].
Ducharme, Francine M. ;
Lemire, Chantal ;
Noya, Francisco J. D. ;
Davis, G. Michael ;
Alos, Nathalie ;
Leblond, Helene ;
Savdie, Cheryl ;
Collet, Jean-Paul ;
Khomenko, Lyudmyla ;
Rivard, Georges ;
Platt, Robert W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (04) :339-353